Species-Level Analysis of Human Gut Microbiota With Metataxonomics

Abstract

The current understanding of human gut microbial community is mainly limited to taxonomic features at the genus level. Here, we examined the human gut microbial community at the species level by metataxonomics. To achieve this purpose, a high-throughput approach involving operational phylogenetic unit analysis of the near full-length 16S ribosomal RNA (rRNA) gene sequence was used. A total of 1,235 species-level phylotypes (SLPs) were classified in the feces of 120 Chinese healthy individuals, including 461 previously classified species, 358 potentially new species, and 416 potentially new taxa, which were categorized into low, medium, and high prevalent bacteria groups based on their prevalence. Each individual harbored 186 ± 51 SLPs on average. There was no universal bacterial species shared by all the individuals. However, 90 ± 19 of 116 SLPs were shared in the high prevalent bacteria group. Thirty-two out of thirty-eight species in the high prevalent bacteria group detected in this study were also found in at least one previous study on human gut microbiota based on either culture-dependent or culture-independent approaches. Through compositional analysis, a hierarchical clustering of the prevalence and relative abundance of the 1,235 SLPs revealed two types of gut microbial communities, which were dominated by Prevotella copri and Bacteroides vulgatus, respectively. The type dominated by P. copri was more prevalent in northern China, while the B. vulgatus-dominant type was more prevalent in southern China. Therefore, P-and B-type gut microbial communities in China were proposed. It was found that 166 out of 461 known bacterial species have been previously reported as potential pathogens, and the individuals sampled for this study harbored 20 of these potential pathogenic species on average. The top two most abundant and prevalent potential pathogenic species were Klebsiella pneumoniae and Bacteroides fragilis.

The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus

“…Most of the research to date has revealed taxonomic groups in the gut at the genus level, and not at the species level, due to technical limitations. To counter this limitation, recent studies introduced a gut microbiome analysis method to make a possible profile at the species level [ 190 , 191 , 192 ]. In the future, these methods to analyze the gut microbiome could help clarify the relationship between metformin and the gut microbiome.…”

Metagenomics: a path to understanding the gut microbiome

“…However, culture-based approaches that are the cornerstone of microbiology have historically been a bottleneck in holobiont studies, due to the challenges associated with isolating, culturing, and subsequently studying the sheer number and diversity of microorganisms present in the human microbiome (Lloyd-Price et al 2016). Sequencebased approaches indicate that between 150 and 200 unique bacterial species reside in a healthy human gut (Qin et al 2010;Yang et al 2020), many of which have, until recently, been considered unculturable (Walker et al 2014). The number and diversity of other key members of the microbiome, such as viruses and fungi are more difficult to predict (Hallen-Adams and Suhr 2017;Sutton and Hill 2019).…”

Strategies for Enhancement of Live-Attenuated Salmonella-Based Carrier Vaccine Immunogenicity

“…Certain sub-species of B. fragilis, designated as Enterotoxigenic B. fragilis (ETBF), carry a unique pathogenicity island (BfPAI) encoding a potent metalloprotease enterotoxin called Bacteroides fragilis toxin, or BFT [ 24 ]. Despite carrying BfPAI, ETBF can be detected as commensal organisms in the colon of healthy individuals displaying no obvious signs of disease [ 61 , 62 ]. It has been demonstrated that the two-component signal transduction system RprX/Y downregulates BFT to maintain intestinal homeostasis and prevent disease [ 63 ].…”